Analyze Diet
Cell biology and toxicology2004; 20(1); 41-54; doi: 10.1023/b:cbto.0000021154.01035.f9

The effect of enrofloxacin on cell proliferation and proteoglycans in horse tendon cells.

Abstract: Fluoroquinolone antibiotics have been used widely in humans and domestic animals, including horses, because of their broad-spectrum bactericidal activity, and relative safety. The use of fluoroquinolones, however, is not without risk. Tendonitis and spontaneous tendon rupture have been reported in people during or following therapy with fluoroquinolones. We have studied the effects of enrofloxacin, a fluoroquinolone antibiotic used commonly in domestic animals, on tendon cell cultures established from equine superficial digital flexor tendons. Effects on cell proliferation and morphology were studied using cell counting and scanning electron microscopy. Monosaccharide content and composition was determined by gas chromatography-mass spectrometry analysis. Western and Northern blot analyses were utilized to evaluate the synthesis and expression of two proteoglycans, biglycan and decorin. Our data demonstrate that enrofloxacin inhibits cell proliferation, induces morphological changes, decreases total monosacharide content and alters small proteoglycan synthesis at the glycosylation level in equine tendon cell cultures. These effects are more pronounced in juvenile tendon cells than in adult equine tendon cells. We hypothesize that morphological changes and inhibition of cell proliferation are a result of impaired production of biglycan and decorin, proteoglycans involved in fibrillogenesis of collagen, the most important structural component of the tendon of enrofloxacin-treated tendon cells. Our findings suggest that fluoroquinolones should be used with caution in horses, especially in foals.
Publication Date: 2004-05-04 PubMed ID: 15119847DOI: 10.1023/b:cbto.0000021154.01035.f9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research explores the effects of a fluoroquinolone antibiotic enrofloxacin on horse tendon cell cultures. The researchers found that enrofloxacin interferes with cell proliferation and proteoglycans, which play a vital role in collagen formation, the crucial structural component of tendons.

Study Methodology

  • The researchers examined the impact of enrofloxacin on horse tendon cells by setting up cell cultures from the superficial digital flexor tendons of equines – an area commonly targeted by the antibiotic.
  • The cell cultures were then observed for any change in cell proliferation (growth and multiplication of cells) and morphology (form and structure of cells) through methods like cell counting and scanning electron microscopy, an imaging technique to observe fine cellular details.
  • Monosaccharide content and composition – essentially sugar molecules that make part of more complex molecules like proteins – was analyzed using gas chromatography-mass spectrometry, a method widely used for identifying different substances within a test sample.
  • Western and Northern blot techniques – used for detection of proteins and RNA respectively – were employed to assess the synthesis and expression of two proteoglycans, biglycan and decorin, which are critical in collagen formation.

Results and Interpretation

  • The study showed that enrofloxacin inhibits cell proliferation and induces changes in the cell’s structure. This was accompanied by a decrease in the total monosaccharide content and alterations in proteoglycan synthesis, particularly in the glycosylation level (a process where sugars are added to proteins).
  • This effect was more pronounced in juvenile tendon cells compared to adult equine tendon cells, suggesting that young horses might be more susceptible to the adverse effects of enrofloxacin.
  • The resulting morphological changes and inhibition of cell proliferation were theorized to be a result of impaired production of biglycan and decorin proteoglycans. These proteoglycans are crucial in the formation of collagen fibrils, major components of tendons.

Conclusion and Recommendations

  • The study provides valuable insight into potential risks associated with the use of fluoroquinolones, particularly enrofloxacin, in horses. The changes induced by enrofloxacin can affect the structural integrity and functionality of tendons.
  • Therefore, the researchers caution against the use of fluoroquinolones in horses, especially in foals, due to potential detrimental effects to tendon health. Further research may be needed to explore safer alternatives or mitigating strategies.

Cite This Article

APA
Yoon JH, Brooks RL, Khan A, Pan H, Bryan J, Zhang J, Budsberg SC, Mueller PO, Halper J. (2004). The effect of enrofloxacin on cell proliferation and proteoglycans in horse tendon cells. Cell Biol Toxicol, 20(1), 41-54. https://doi.org/10.1023/b:cbto.0000021154.01035.f9

Publication

ISSN: 0742-2091
NlmUniqueID: 8506639
Country: Switzerland
Language: English
Volume: 20
Issue: 1
Pages: 41-54

Researcher Affiliations

Yoon, J H
  • The Soft Tissue Center, Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602-7388, USA.
Brooks, R L
    Khan, A
      Pan, H
        Bryan, J
          Zhang, J
            Budsberg, S C
              Mueller, P O E
                Halper, J

                  MeSH Terms

                  • Animals
                  • Antineoplastic Agents / toxicity
                  • Apoptosis
                  • Biglycan
                  • Blotting, Northern
                  • Blotting, Western
                  • Carbohydrates / chemistry
                  • Cell Division / drug effects
                  • Chromatography, Gas
                  • Decorin
                  • Electrophoresis, Polyacrylamide Gel
                  • Enrofloxacin
                  • Extracellular Matrix Proteins
                  • Fluoroquinolones / toxicity
                  • Horses
                  • Mass Spectrometry
                  • Microscopy, Electron, Scanning
                  • Proteoglycans / chemistry
                  • Proteoglycans / metabolism
                  • Quinolones / toxicity
                  • RNA / chemistry
                  • Tendons / drug effects
                  • Time Factors

                  Citations

                  This article has been cited 11 times.
                  1. James S, Daffy J, Cook J, Samiric T. Short-Term Exposure to Ciprofloxacin Reduces Proteoglycan Loss in Tendon Explants. Genes (Basel) 2022 Nov 25;13(12).
                    doi: 10.3390/genes13122210pubmed: 36553476google scholar: lookup
                  2. Grabowski Ł, Gaffke L, Pierzynowska K, Cyske Z, Choszcz M, Węgrzyn G, Węgrzyn A. Enrofloxacin-The Ruthless Killer of Eukaryotic Cells or the Last Hope in the Fight against Bacterial Infections?. Int J Mol Sci 2022 Mar 26;23(7).
                    doi: 10.3390/ijms23073648pubmed: 35409007google scholar: lookup
                  3. James S, Schuijers J, Daffy J, Cook J, Samiric T. Ciprofloxacin reduces tenocyte viability and proteoglycan synthesis in short-term explant cultures of equine tendon. PeerJ 2021;9:e12003.
                    doi: 10.7717/peerj.12003pubmed: 34540363google scholar: lookup
                  4. Siengdee P, Pradit W, Chomdej S, Nganvongpanit K. Determination of two fluoroquinolones and their combinations with hyaluronan effect in in vitro canine cartilage explants. PeerJ 2019;7:e6553.
                    doi: 10.7717/peerj.6553pubmed: 30881764google scholar: lookup
                  5. Celani G, Tulini SMR, Montesano C, Zezza D, Sergi M, Varasano V, Mortellaro CM, Compagnone D, Amorena M, Petrizzi L. Pharmacokinetics of marbofloxacin administered via intravenous regional limb perfusion in dairy cows: evaluation of two different tourniquets. Vet Rec Open 2017;4(1):e000227.
                    doi: 10.1136/vetreco-2017-000227pubmed: 29018533google scholar: lookup
                  6. Endo Y, Ishikawa Y, Arima D, Mae N, Iwamoto Y, Korosue K, Tsuzuki N, Hobo S. Effects of pre-shipping enrofloxacin administration on fever and blood properties in adult Thoroughbred racehorses transported a long distance. J Vet Med Sci 2017 Mar 18;79(3):464-466.
                    doi: 10.1292/jvms.16-0465pubmed: 28111418google scholar: lookup
                  7. Sejersen MH, Frost P, Hansen TB, Deutch SR, Svendsen SW. Proteomics perspectives in rotator cuff research: a systematic review of gene expression and protein composition in human tendinopathy. PLoS One 2015;10(4):e0119974.
                    doi: 10.1371/journal.pone.0119974pubmed: 25879758google scholar: lookup
                  8. Endo Y, Tsuchiya T, Omura T, Nakai K, Korosue K, Ishimaru M, Ishikawa Y, Hobo S. Effects of pre-shipping marbofloxacin administration on fever and blood properties in healthy Thoroughbreds transported a long distance. J Vet Med Sci 2015 Jan;77(1):75-9.
                    doi: 10.1292/jvms.14-0336pubmed: 25720808google scholar: lookup
                  9. Lim S, Hossain MA, Park J, Choi SH, Kim G. The effects of enrofloxacin on canine tendon cells and chondrocytes proliferation in vitro. Vet Res Commun 2008 Mar;32(3):243-53.
                    doi: 10.1007/s11259-007-9024-8pubmed: 18027099google scholar: lookup
                  10. Cardinaux EM, Oltmanns H, Beineke A, Meißner J, Geburek F. Pharmacological alternatives to oxytetracycline as potential treatment of flexural limb deformities in foals: a preliminary in vitro cell viability and proliferation study. Sci Rep 2025 May 6;15(1):15762.
                    doi: 10.1038/s41598-025-00311-zpubmed: 40328831google scholar: lookup
                  11. Duman E, Müller-Deubert S, Pattappa G, Stratos I, Sieber SA, Clausen-Schaumann H, Sarafian V, Shukunami C, Rudert M, Docheva D. Fluoroquinolone-Mediated Tendinopathy and Tendon Rupture. Pharmaceuticals (Basel) 2025 Jan 30;18(2).
                    doi: 10.3390/ph18020184pubmed: 40005998google scholar: lookup